Entero Therapeutics, Inc. (NASDAQ:ENTO – Get Free Report) was the recipient of a large decrease in short interest in February. As of February 28th, there was short interest totalling 96,000 shares, a decrease of 31.3% from the February 13th total of 139,800 shares. Based on an average trading volume of 309,400 shares, the short-interest ratio is currently 0.3 days. Approximately 2.1% of the shares of the company are short sold.
Entero Therapeutics Price Performance
Shares of NASDAQ:ENTO traded up $0.03 during trading on Monday, hitting $0.51. 77,602 shares of the stock were exchanged, compared to its average volume of 395,784. Entero Therapeutics has a 1-year low of $0.19 and a 1-year high of $3.16. The company’s fifty day simple moving average is $0.53 and its 200-day simple moving average is $0.52.
Entero Therapeutics Company Profile
Featured Stories
- Five stocks we like better than Entero Therapeutics
- Basic Materials Stocks Investing
- Occidental Petroleum: 4 Reasons to Love These Prices
- Profitably Trade Stocks at 52-Week Highs
- Super Micro’s International Presence Makes It a Winning Stock
- 3 Healthcare Dividend Stocks to Buy
- Grocery Outlet Insider and Institutional Buyers Signal Bottom
Receive News & Ratings for Entero Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entero Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.